Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AproDerm
- Development stage
- Unknown
- Lead developer
- Fontus Health
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
AproDerm is a range of topical emollients developed by Fontus Health for the management of dry skin conditions, including eczema, psoriasis, and dermatitis. The primary formulations contain white soft paraffin (15%) and liquid paraffin (6%) as active ingredients. These substances function as occlusive agents, forming a protective layer on the skin's surface to trap moisture, hydrate the stratum corneum, and shield the skin from environmental irritants. AproDerm products are specifically formulated to be free from common sensitizers such as sodium lauryl sulfate (SLS), parabens, fragrances, and artificial colors, making them suitable for patients of all ages, including infants from birth. The range includes cream, gel, and ointment variants to accommodate different patient preferences and severity of skin dryness.
- Brand names
- AproDerm
- Other names
- AproDerm Emollient CreamAproDerm GelAproDerm Ointment
Beyond the preview
Go deeper on AproDerm.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AproDerm.